BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33820507)

  • 21. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
    Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
    Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coumarin hybrids as novel therapeutic agents.
    Sandhu S; Bansal Y; Silakari O; Bansal G
    Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coumarin derivatives with anticancer activities: An update.
    Song XF; Fan J; Liu L; Liu XF; Gao F
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pickering emulsions stabilized nanocellulosic-based nanoparticles for coumarin and curcumin nanoencapsulations: In vitro release, anticancer and antimicrobial activities.
    Asabuwa Ngwabebhoh F; Ilkar Erdagi S; Yildiz U
    Carbohydr Polym; 2018 Dec; 201():317-328. PubMed ID: 30241825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review on Anti-urease Potential of Coumarins.
    Asghar H; Asghar H; Asghar T
    Curr Drug Targets; 2021; 22(17):1926-1943. PubMed ID: 33618646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells.
    Maleki EH; Bahrami AR; Sadeghian H; Matin MM
    Toxicol In Vitro; 2020 Mar; 63():104745. PubMed ID: 31830504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in the Chemistry of Naturally Occurring Coumarins.
    Sarker SD; Nahar L
    Prog Chem Org Nat Prod; 2017; 106():241-304. PubMed ID: 28762091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
    Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
    Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
    Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Biological Profiles of Coumarin Scaffold - Part 1.
    de Carvalho da Silva F; Ferreira VF; da Silva Magalhaes Forezi L
    Curr Top Med Chem; 2017; 17(29):3171-3172. PubMed ID: 29475429
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents.
    Shi Y; Zhou CH
    Bioorg Med Chem Lett; 2011 Feb; 21(3):956-60. PubMed ID: 21215620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
    Thakur A; Singla R; Jaitak V
    Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G; Sun S; Wu B; Liu J
    Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
    Bhatia R; Rawal RK
    Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review: Biologically active 3,4-heterocycle-fused coumarins.
    Salehian F; Nadri H; Jalili-Baleh L; Youseftabar-Miri L; Abbas Bukhari SN; Foroumadi A; Tüylü Küçükkilinç T; Sharifzadeh M; Khoobi M
    Eur J Med Chem; 2021 Feb; 212():113034. PubMed ID: 33276991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer.
    Venkata Sairam K; Gurupadayya BM; Chandan RS; Nagesha DK; Vishwanathan B
    Curr Drug Deliv; 2016; 13(2):186-201. PubMed ID: 26135671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Review on Pharmacological Properties of Coumarins.
    Srikrishna D; Godugu C; Dubey PK
    Mini Rev Med Chem; 2018; 18(2):113-141. PubMed ID: 27488585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of coumarin derivatives in pharmacotherapy of breast cancer.
    Musa MA; Cooperwood JS; Khan MO
    Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.